149 related articles for article (PubMed ID: 8079344)
1. Fibroblasts that express aromatic amino acid decarboxylase have increased sensitivity to the synergistic cytotoxicity of L-dopa and manganese.
Montine TJ; Underhill TM; Linney E; Graham DG
Toxicol Appl Pharmacol; 1994 Sep; 128(1):116-22. PubMed ID: 8079344
[TBL] [Abstract][Full Text] [Related]
2. Induction of dopamine biosynthesis by l-DOPA in PC12 cells: implications of L-DOPA influx and cyclic AMP.
Jin CM; Yang YJ; Huang HS; Lim SC; Kai M; Lee MK
Eur J Pharmacol; 2008 Sep; 591(1-3):88-95. PubMed ID: 18602388
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus-mediated gene transfer of human aromatic L-amino acid decarboxylase protects mixed striatal primary cultures from L-DOPA toxicity.
Doroudchi MM; Liauw J; Heaton K; Zhen Z; Forsayeth JR
J Neurochem; 2005 May; 93(3):634-40. PubMed ID: 15836622
[TBL] [Abstract][Full Text] [Related]
4. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
Biggs CS; Fisher A; Starr MS
Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
[TBL] [Abstract][Full Text] [Related]
5. Effects of scoparone on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells.
Yang YJ; Lee HJ; Huang HS; Lee BK; Choi HS; Lim SC; Lee CK; Lee MK
J Neurosci Res; 2009 Jun; 87(8):1929-37. PubMed ID: 19185027
[TBL] [Abstract][Full Text] [Related]
6. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration.
Lee WY; Lee EA; Jeon MY; Kang HY; Park YG
Exp Neurol; 2006 Jan; 197(1):215-24. PubMed ID: 16269145
[TBL] [Abstract][Full Text] [Related]
7. Effects of asimilobine on dopamine biosynthesis and l-DOPA-induced cytotoxicity in PC12 cells.
Jin CM; Lee JJ; Kim YK; Ryu SY; Lim SC; Hwang BY; Lee CK; Lee MK
J Asian Nat Prod Res; 2008; 10(7-8):747-55. PubMed ID: 18696327
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of L-dopa and aromatic L-amino acid-decarboxylase in the rat retina.
Nguyen-Legros J; Krieger M; Simon A
Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):2906-15. PubMed ID: 8206708
[TBL] [Abstract][Full Text] [Related]
9. [Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro].
Su Y; Duan CL; Zhao CL; Zhao HY; Xu QY; Yang H
Sheng Li Xue Bao; 2003 Oct; 55(5):583-8. PubMed ID: 14566408
[TBL] [Abstract][Full Text] [Related]
10. L-dopa as substrate for human duodenal catechol-O-methyltransferase and aromatic L-amino acid decarboxylase.
Schultz E
Biomed Chromatogr; 1990 Nov; 4(6):242-4. PubMed ID: 2289048
[TBL] [Abstract][Full Text] [Related]
11. Dopamine synthesis by non-dopaminergic neurons expressing individual complementary enzymes of the dopamine synthetic pathway in the arcuate nucleus of fetal rats.
Ugrumov MV; Melnikova VI; Lavrentyeva AV; Kudrin VS; Rayevsky KS
Neuroscience; 2004; 124(3):629-35. PubMed ID: 14980733
[TBL] [Abstract][Full Text] [Related]
12. Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.
Sánchez-Pernaute R; Harvey-White J; Cunningham J; Bankiewicz KS
Mol Ther; 2001 Oct; 4(4):324-30. PubMed ID: 11592835
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic assay for perfluoro-tagged metabolites of l-DOPA using crude lysate from E. coli transformed with pKKAADCII.
Dingman S; Snyder-Leiby T; Mack DJ; Thomas R; Guo C
Appl Microbiol Biotechnol; 2004 May; 64(4):556-9. PubMed ID: 14634798
[TBL] [Abstract][Full Text] [Related]
14. Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats.
Buck K; Ferger B
Neurobiol Dis; 2008 Feb; 29(2):210-20. PubMed ID: 17920284
[TBL] [Abstract][Full Text] [Related]
15. Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment.
Silva MA; Mattern C; Häcker R; Tomaz C; Huston JP; Schwarting RK
Synapse; 1997 Dec; 27(4):294-302. PubMed ID: 9372552
[TBL] [Abstract][Full Text] [Related]
16. Binding of dopamine and 3-methoxytyramine as l-DOPA metabolites to human alpha(2)-adrenergic and dopaminergic receptors.
Alachkar A; Brotchie JM; Jones OT
Neurosci Res; 2010 Jul; 67(3):245-9. PubMed ID: 20302892
[TBL] [Abstract][Full Text] [Related]
17. Localization of L-DOPA uptake and decarboxylating neuronal structures in the cat brain using dopamine immunohistochemistry.
Kitahama K; Geffard M; Araneda S; Arai R; Ogawa K; Nagatsu I; Pequignot JM
Brain Res; 2007 Sep; 1167():56-70. PubMed ID: 17692830
[TBL] [Abstract][Full Text] [Related]
18. Catalponol enhances dopamine biosynthesis and protects against L-DOPA-induced cytotoxicity in PC12 cells.
Huang HS; Han XH; Hwang BY; Park JI; Yoo SK; Choi HS; Lim SC; Lee MK
J Asian Nat Prod Res; 2009 Oct; 11(10):867-75. PubMed ID: 20183248
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the involvement of P-glycoprotein on the extrusion of taken up L-DOPA in cyclosporine A treated LLC-PK1 cells.
Soares-da-Silva P; Serrão MP; Vieira-Coelho MA; Pestana M
Br J Pharmacol; 1998 Jan; 123(1):13-22. PubMed ID: 9484849
[TBL] [Abstract][Full Text] [Related]
20. Dopamine but not l-dopa stimulates neural glutathione metabolism. Potential implications for Parkinson's and other dopamine deficiency states.
Allen GF; Ullah Y; Hargreaves IP; Land JM; Heales SJ
Neurochem Int; 2013 Apr; 62(5):684-94. PubMed ID: 23261515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
